CH
抗体药类似物
Research Grade Crefmirlimab
All
  • CatalogTD-HP158016
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • Synonyms89Zr-IAB22M2C,IAB22M2C,89Zr-Df-IAB22M2C,CAS:2611099-93-3
  • Specification
    1mg
  • Prices
    ¥询价
Customized service consulting

Research Grade Crefmirlimab


Catalog No. TD-HP158016
Species reactivity Human
Applications Research Grade Biosimilar
Host species Humanized
Isotype (scFv-kappa-heavy) -h- CH3
Expression system Mammalian Cells
Clonality Monoclonal
Target T-cell surface glycoprotein CD8 alpha chain, CD8a, T-lymphocyte differentiation antigen T8/Leu-2, MAL, CD8A
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Purified by ion exchange chromatography.
Accession P01732
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names 89Zr-IAB22M2C,IAB22M2C,89Zr-Df-IAB22M2C,CAS:2611099-93-3
Background Crefmirlimab is a humanized CD8 specific minibody. The minibody (Mb) maintains the specificity of full-length antibodies but has no immune effector functions and is biologically inert.
Note For research use only. Not for use in clinical or therapeutic applications.